Display options
Cite
Bell AF, Carter CS, Steer CD, et al. Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy. Front Genet. 2015;6:243doi: 10.3389/fgene.2015.00243.
Bell, A. F., Carter, C. S., Steer, C. D., Golding, J., Davis, J. M., Steffen, A. D., Rubin, L. H., Lillard, T. S., Gregory, S. P., Harris, J. C., & Connelly, J. J. (2015). Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy. Frontiers in genetics, 6243. https://doi.org/10.3389/fgene.2015.00243
Bell, Aleeca F, et al. "Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy." Frontiers in genetics vol. 6 (2015): 243. doi: https://doi.org/10.3389/fgene.2015.00243
Bell AF, Carter CS, Steer CD, Golding J, Davis JM, Steffen AD, Rubin LH, Lillard TS, Gregory SP, Harris JC, Connelly JJ. Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy. Front Genet. 2015 Jul 21;6:243. doi: 10.3389/fgene.2015.00243. eCollection 2015. PMID: 26257770; PMCID: PMC4508577.
Copy Download .nbib Format: NLM
Share it on

Front Genet. 2015 Jul 21;6:243. doi: 10.3389/fgene.2015.00243. eCollection 2015.

Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy.

Frontiers in genetics

Aleeca F Bell, C S Carter, Colin D Steer, Jean Golding, John M Davis, Alana D Steffen, Leah H Rubin, Travis S Lillard, Steven P Gregory, James C Harris, Jessica J Connelly

Affiliations

  1. Department of Women, Children and Family Health Science, College of Nursing, University of Illinois at Chicago, Chicago IL, USA.
  2. Kinsey Institute and Department of Biology, Indiana University, Bloomington IN, USA.
  3. Centre for Child and Adolescent Health, School of Social and Community Medicine, University of Bristol Bristol, UK.
  4. Department of Psychiatry, University of Illinois at Chicago, Chicago IL, USA.
  5. Department of Psychology, University of Virginia, Charlottesville VA, USA.
  6. Department of Psychiatry and Behavioral Sciences, Developmental Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore MD, USA.

PMID: 26257770 PMCID: PMC4508577 DOI: 10.3389/fgene.2015.00243

Abstract

Postpartum depression (PPD) affects up to 19% of women, negatively impacting maternal and infant health. Reductions in plasma oxytocin levels have been associated with PPD and heritability studies have established a genetic contribution. Epigenetic regulation of the oxytocin receptor gene (OXTR) has been demonstrated and we hypothesized that individual epigenetic variability at OXTR may impact the development of PPD and that such variability may be central to predicting risk. This case-control study is nested within the Avon Longitudinal Study of Parents and Children and included 269 cases with PPD and 276 controls matched on age group, parity, and presence or absence of depressive symptoms in pregnancy as assessed by the Edinburgh Postnatal Depression Scale. OXTR DNA methylation (CpG site -934) and genotype (rs53576 and rs2254298) were assayed from DNA extracted from blood collected during pregnancy. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association of elevated symptoms of PPD with genotype, methylation, and their interaction adjusted for psychosocial factors (n = 500). There was evidence of an interaction between rs53576 and methylation in the OXTR gene amongst women who did not have depression prenatally but developed PPD (p interaction = 0.026, adjusted for covariates, n = 257). Those women with GG genotype showed 2.63 greater odds of PPD for every 10% increase in methylation level (95% CI: 1.37, 5.03), whereas methylation was unrelated to PPD amongst "A" carriers (OR = 1.00, 95% CI: 0.58, 1.73). There was no such interaction among women with PPD and prenatal depression. These data indicate that epigenetic variation that decreases expression of OXTR in a susceptible genotype may play a contributory role in the etiology of PPD.

Keywords: ALSPAC; DNA methylation; OXTR; epigenetics; oxytocin; oxytocin receptor; postpartum depression; rs53576

References

  1. Horm Behav. 2013 Apr;63(4):615-24 - PubMed
  2. Prog Brain Res. 2008;170:79-90 - PubMed
  3. Dev Psychobiol. 2007 Apr;49(3):290-302 - PubMed
  4. Int J Epidemiol. 2013 Feb;42(1):111-27 - PubMed
  5. Arch Psychiatr Nurs. 1998 Feb;12(1):12-20 - PubMed
  6. Front Neurosci. 2013 Oct 31;7:199 - PubMed
  7. J Adv Nurs. 2008 Nov;64(3):304-14 - PubMed
  8. Psychoneuroendocrinology. 2011 Jan;36(1):144-7 - PubMed
  9. BMC Med. 2012 Apr 17;10:38 - PubMed
  10. PLoS One. 2014 Mar 12;9(3):e90465 - PubMed
  11. Womens Health (Lond). 2012 Nov;8(6):659-72 - PubMed
  12. J Womens Health (Larchmt). 2013 Apr;22(4):352-61 - PubMed
  13. Nurs Res. 1995 Sep-Oct;44(5):298-304 - PubMed
  14. Hum Mol Genet. 2012 Nov 1;21(21):4751-60 - PubMed
  15. Int J Epidemiol. 2013 Feb;42(1):97-110 - PubMed
  16. Front Neurosci. 2013 Jan 10;6:194 - PubMed
  17. J Child Psychol Psychiatry. 2013 Nov;54(11):1223-30 - PubMed
  18. Eur J Hum Genet. 2015 Jun;23(6):854-62 - PubMed
  19. J Fam Psychol. 2012 Jun;26(3):431-42 - PubMed
  20. Nat Commun. 2013;4:2166 - PubMed
  21. Evid Rep Technol Assess (Summ). 2005 Feb;(119):1-8 - PubMed
  22. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3308-13 - PubMed
  23. Psychoneuroendocrinology. 2014 May;43:11-9 - PubMed
  24. Psychiatr Genet. 2014 Apr;24(2):45-51 - PubMed
  25. Am J Psychiatry. 2013 Oct;170(10):1161-8 - PubMed
  26. Soc Cogn Affect Neurosci. 2011 Jun;6(3):294-300 - PubMed
  27. Trends Neurosci. 2012 Nov;35(11):649-59 - PubMed
  28. Neuropsychopharmacology. 2011 Aug;36(9):1886-93 - PubMed
  29. JAMA Psychiatry. 2013 May;70(5):490-8 - PubMed
  30. Nat Neurosci. 2009 Dec;12(12):1559-66 - PubMed
  31. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15118-22 - PubMed
  32. BMJ. 2001 Aug 4;323(7307):257-60 - PubMed
  33. Br J Psychiatry. 1987 Jun;150:782-6 - PubMed
  34. Nat Rev Neurosci. 2008 Jan;9(1):11-25 - PubMed
  35. Horm Behav. 2012 Mar;61(3):380-91 - PubMed
  36. Harv Rev Psychiatry. 2009;17(2):147-56 - PubMed
  37. Am J Public Health. 2013 Oct;103 Suppl 1:S9-11 - PubMed
  38. Dev Psychopathol. 2011 May;23(2):439-52 - PubMed
  39. J Affect Disord. 2015 Feb 1;172:265-73 - PubMed
  40. Nat Neurosci. 2004 Aug;7(8):847-54 - PubMed
  41. Biol Psychiatry. 2014 Sep 1;76(5):367-76 - PubMed
  42. Paediatr Perinat Epidemiol. 2001 Jan;15(1):74-87 - PubMed
  43. Am J Med Genet B Neuropsychiatr Genet. 2007 Jan 5;144B(1):101-5 - PubMed
  44. Biol Res Nurs. 2010 Jul;12(1):73-83 - PubMed
  45. Biol Psychiatry. 2012 Aug 1;72(3):175-81 - PubMed
  46. Annu Rev Clin Psychol. 2013;9:379-407 - PubMed
  47. Psychoneuroendocrinology. 1998 Nov;23(8):779-818 - PubMed
  48. Trends Cogn Sci. 2011 Jul;15(7):301-9 - PubMed
  49. Annu Rev Psychol. 2014;65:17-39 - PubMed
  50. Eur J Psychotraumatol. 2013 Sep 18;4:null - PubMed
  51. Physiol Rev. 2001 Apr;81(2):629-83 - PubMed
  52. Biochem Biophys Res Commun. 2001 Dec 7;289(3):681-6 - PubMed
  53. Psychoneuroendocrinology. 2009 Nov;34(10):1506-14 - PubMed
  54. Dev Psychopathol. 2014 Feb;26(1):33-40 - PubMed
  55. BMC Med. 2009 Oct 22;7:62 - PubMed
  56. Front Hum Neurosci. 2012 Oct 10;6:280 - PubMed
  57. Front Neurosci. 2013 May 23;7:83 - PubMed
  58. J Affect Disord. 2010 Dec;127(1-3):31-7 - PubMed
  59. Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16096-101 - PubMed
  60. Front Neurosci. 2013 Jul 23;7:128 - PubMed

Publication Types

Grant support